Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hansa Biopharma to participate in two upcoming investor conferences

Hansa Biopharma has been invited to participate in two global biotech and healthcare conferences during March including Cowen Annual Health Care Conference in Boston and Carnegie Nordic Healthcare Seminar in Stockholm.Lund, Sweden February 25, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company’s management team will participate in the following upcoming investor conferences:  •    Cowen and Company’s 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, with a presentation at 4:10 PM

InDex Pharmaceuticals publishes mechanism of action data for cobitolimod in scientific journal

February 25, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company’s lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper, published in the peer-reviewed Journal of Crohns and Colitis (JCC), shows that the Toll-like receptor 9 (TLR9) agonist cobitolimod can modulate the immune system in ulcerative colitis by balancing the mucosal Th17/Treg cell response. The publication has also been highlighted in the journal podcast.Cobitolimod recently met

Herantis Pharma Plc announces topline results of Phase 1-2 CDNF trial

Topline analysis confirms positive safety and tolerability of CDNF in advanced-stage Parkinson’s disease patients, with encouraging biological responses as measured by PET imaging in some patients. Results from the second part of trial, in which all patients will receive CDNF for an additional six months, are expected in Q3 2020.Herantis Pharma PlcCompany release, insider information 25 February 2020 at 9:00 AM Eastern European Time Herantis Pharma Plc (“Herantis” or “Company”) announced today the topline results from the ongoing Phase 1-2 clinical trial examining Herantis’ proprietary

Lipidor AB re-publishes year-end report for 2019

Yesterday, 24 February at 4.59pm (CET), Lipidor AB (publ) published our year-end report for 2019 one day earlier than announced. We hereby re-publish the year-end report 2019 on the date and time earlier communicated.Summary of year-end report - fourth quarter and reporting period 2019 During the fourth quarter, the company's clinical phase III study of the drug candidate AKP01 against psoriasis was completed. The study included 277 randomized patients and was carried out by Cadila Pharmaceuticals in India. After the reporting period, positive results from the study were announced. The

Sivers IMA Launches new 5G NR mmWave System Test Platform

Kista, Sweden – February 25, 2020 – Sivers IMA Holding AB (Nasdaq First North Growth Market: SIVE) today announced the launch of the new 5G NR mmWave System Test Platform with support for both licensed 5G NR 24-29.5 GHz and unlicensed 5G NR-U 57-71 GHz (pre-3GPP R17 support).The new 5G NR mmWave System Test Platform supports the 5G New Radio (NR) standard including phased array antenna modules for both licensed and unlicensed 5G-NR bands and the Xilinx Radio Frequency System-on-Chip (RFSoC) ZCU111 platform. The platform also includes a modem simulation framework using Matlab, allowing radio

Investor Report

To view this report in PDF, please click on the following link:  http://www.rns-pdf.londonstockexchange.com/rns/9780D_1-2020-2-25.pdf     RBC Covered Bond Programme Monthly Investor Report Calculation Date:                                               1/31/2020     This report contains information regarding assets pledged as security (theCover Pool) in respect of the obligations under the Covered Bonds issued underRBC's Global Covered Bond Programme as of the indicated Calculation Date.  Thecomposition of the Cover Pool will change as Loans are added and removed

1st Quarter Results

To view the Q1 2020 Report to Shareholders in PDF, please click on the link below.  http://www.rns-pdf.londonstockexchange.com/rns/9782D_1-2020-2-25.pdf  Royal Bank of Canada first quarter 2020 results   All amounts are in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted.               Net   Diluted EPS(1) $2.40   ROE(2) 17.6%   CET1 Ratio 12.0% Income Strong 12% growth YoY

New shares of Konecranes Plc registered with the trade register

KONECRANES PLC STOCK EXCHANGE RELEASE February 25, 2020 at 09.00 EETNew shares of Konecranes Plc registered with the trade registerA total of 300,000 new shares (the “New Shares”) issued in Konecranes Plc's (the “Company”) share issue to the Company itself without consideration have been registered with the Trade Register on February 25, 2020. Following the registration of the New Shares, the total number of the Company’s shares is 79,221,906 shares, of which 379,980 shares in total are held by the Company.The New Shares will be admitted to trading together with the Company’s existing

Appoints Ann-Christine Fick as CFO and Michael Wallin as IR

STOCKHOLM, Sweden – Nepa, a leading consumer research and analytics company, which provides solutions to drive brand and sales by increasing market efficiency, has appointed Ann-Christine Fick as the new CFO and member of group management with immediate effect. Ann-Christine has extensive experience in financial reporting and accounting from among others Deloitte and Amfa Bank before taking over as senior finance accountant at Nepa in 2016. Ann-Christine Fick takes over as CFO after P-O Westerlund, who was appointed CEO of Nepa in January this year. "It's a great pleasure to promote

Redeye: Better Collective - Raising the Bet

Redeye raises Better Collective´s base case valuation after a positive Q4’19 report. With Q1’20 off to a strong start, the US performing well, and a potential acquisition in the attractive esport vertical in prospect, we feel even greater conviction in the case. Read more and download the research update: http://bit.ly/32oCZMT Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

Raisio plc: Raisio's converted shares

Raisio plc      Stock Exchange Release, 25 February 2020 RAISIO'S CONVERTED SHARES The Board of Directors of Raisio plc has decided in its meeting held on 11 February 2020 to convert a total of 5,500 restricted shares (series K) into free shares (series V). The decision has been entered in the Trade Register today, on 25 February 2020. The additional lot of free shares in question is admitted to trading on the Nasdaq Helsinki Ltd as of 26 February 2020. Since the beginning of 2020, a total of 5,500 restricted shares of the company have been converted into free shares. The number of

Change in Kamux’s Management Team: CPO Olli Kilpi to take up new responsibilities outside Kamux

KAMUX CORPORATION    Stock Exchange Release    25 February 2020 at 8:45   Change in Kamux’s Management Team: CPO Olli Kilpi to take up new responsibilities outside Kamux Mr. Olli Kilpi, Kamux’s CPO and Member of the Management Team, has decided to leave to take up new responsibilities outside the company. He has worked in the company since 2017, and will continue in his current position until 22 May, 2020. "I would like to express my warmest thanks to Mr. Olli Kilpi for the great work he has done for Kamux in company’s internationalization and growth. I wish Olli all the best in

Progress in the South African Block 2B license: Crown Energy’s partner Africa Energy signs two farmout agreements

Crown Energy AB (“Crown Energy” or “The Company”) are pleased to inform, that on February 25 2020, Africa Energy Corp (“Africa Energy”), our partner and also the operator of Block 2B offshore South Africa, announced the execution of two farmout agreements whereby Africa Energy will transfer an aggregate 62.5 per cent participating interest in the Exploration Right for Block 2B in consideration for a carry through the next exploration well, Gazania-1, which is expected to spud by the end of 2020. Africa Energy will retain a 27.5 per cent participating interest in Block 2B. Andreas

Invitation to investor meeting at ESTRO in Vienna

STOCKHOLM, February 25, 2020 – Elekta (EKTA-B.ST) invites analysts and investors to a meeting on April 4, in conjunction with the Annual Meeting of the European Society for Radiation Oncology (ESTRO), in Vienna, Austria. The investor meeting will be held on Saturday, April 4, at 08:00 – 10:00 a.m. local time, at the Hilton Vienna Danube Waterfront. Speakers at the meeting will include Richard Hausmann, Elekta’s President and CEO, and other members of Elekta’s management team. To attend, please register via https://bit.ly/37PW5gh. Elekta will also host a user meeting on Friday,

Panoro Energy Farms into South Africa Exploration License

Oslo, February 25, 2020, Panoro Energy ASA (the “Company” or “Panoro” with OSE ticker: “PEN”) is pleased to announce that it has signed a Farm Out Agreement (“FOA”) with a subsidiary of Africa Energy Corp. (“AEC”), part of the Lundin Group of Companies, which entails a wholly-owned subsidiary of Panoro acquiring a 12.5% interest in Block 2B located in the Orange Basin, offshore the west coast of South Africa. The exploration block has an exciting rift basin oil play, with an existing oil discovery and near-term plans to drill the Gazania-1 well targeting best estimated gross prospective

Africa Energy Signs Farmout Agreements for Block 2B Offshore South Africa

VANCOUVER, February 25, 2020 /CNW/ – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, is pleased to announce the execution of two farmout agreements whereby the Company will transfer an aggregate 62.5% participating interest in the Exploration Right for Block 2B offshore South Africa in consideration for a carry through the next exploration well, Gazania-1, which is expected to spud by the end of 2020. Africa Energy will retain a 27.5% participating interest

COSEL expands microprocessor controlled power supplies offering for industrial and semiconductor industries

•    High power density (2.1W/cm3)•    Low profile ( 1U )•    Harmonic attenuator complying with IEC61000-3-2 class A•    Active current sharing and easy paralleling - up to 10 units•    High reliability and 3-year warranty Cosel Co, Ltd (6905: Tokyo) today announced the addition of a 3000W AC/DC enclosed power supply for industrial and demanding semiconductors applications. Designed with advanced built-in COSEL’s digital microprocessor technology, the FETA3000BA  includes active current sharing, making it simple to parallel up to 10

Itiviti recognized for Best Trading and Execution Platform at Asian Private Banker Technology Awards

Hong Kong, February 25, 2020 – Itiviti, a leading technology and service provider to financial institutions worldwide, today announced that its multi-asset trading and execution solution has won  Best Trading and Execution Platform at the 5[th] Asian Private Banker Technology Awards. The Technology Awards are judged by members of Asian Private Banker’s team.A growing number of Asian private bankers and wealth managers rely on Itiviti’s next-generation platform to handle complex order aggregation while automating high volume order flows taking advantage of Itiviti’s advanced compliance and

Noreco announces fourth quarter 2019 results

Oslo, 25 February 2020: Norwegian Energy Company ASA (“Noreco”) today announced its result for the fourth quarter of 2019. The fourth quarter result was the first full quarter reflecting the acquisition of Shell Olie- og Gasudvinding Danmark B.V. and the successful shut-in of Tyra as part of the redevelopment plan. Halfdan, Gorm and Dan contributed to a stable production of 31.7 mboepd, in line with Company guidance. Highlights•    Net production of 31.7 thousand barrels of oil equivalents per day ("mboepd"), post shut-in of Tyra•    Adjusted EBITDA of USD 116 million•    Cash

Observe Medical ASA: Q4 2019 financial results

Oslo, 25 February 2020 – Observe Medical ASA (OSE: OBSERV) continued implementation of its growth strategy in the fourth quarter of 2019, including the commercialization of its first product Sippi®. “In the fourth quarter of 2019, we have taken important steps in the commercialization of Sippi. In parallel we have strengthened our foundation for value creation and growth by establishing Observe Medical as a standalone publicly listed company. We have a new leadership team in place, a strong board of directors, and we have established good corporate infrastructure and internal processes.”

Reduced stress changes profile of various lipid compounds

Reduced stress is linked to changes in the profile of plasma metabolites, a new study from the University of Eastern Finland shows. According to the researchers, the findings can shed light on the associations of psychological well-being with metabolism and the risk of disease. The study was published in Scientific Reports. Psychological stress is known to be associated with obesity, low-grade inflammation and metabolic disorders, but the underlying mechanisms remain poorly understood. In the newly published study, the researchers used metabolite profiling to study whether improved

Operational EBIT of DKK 415 Million for the Fourth Quarter of 2019

The Bakkafrost Group delivered a total operating EBIT of DKK 415.3 million in Q4 2019. Harvested volumes for the Group were 25.9 thousand tonnes gutted weight, whereof 17.9 thousand tonnes were harvested in the Faroe Islands (FO) and 7.9 thousand tonnes in Scotland (SCO). The combined Farming FO and VAP segments made an operational EBIT of DKK 374.9 million. The farming segment made an operational EBIT of DKK 338.3 million in the Faroe Islands (FO) and DKK 18.1 million in Scotland (SCO). Achieved prices and volumes in the Faroese operations increased and thus had a positive effect on the

Pivot Power, an EDF Renewables company, places order with Wärtsilä for 100 MW of energy storage in UK

Wärtsilä Corporation and Pivot Power, Joint press release, 25 February 2020 at 02.01 am EETGrid-scale batteries will provide balancing services for world's largest transmission-connected battery storage network, accelerating the transition to a clean energy future in the United Kingdom. Pivot Power, an EDF Renewables company specialising in battery storage and infrastructure for electric vehicle charging, has placed an order with technology group Wärtsilä to deliver 100 MW of energy storage in the UK. Pivot Power is developing a world-first national network of grid-scale batteries and

Notice to attend the Annual General Meeting of XVIVO Perfusion AB (publ)

The shareholders of XVIVO Perfusion AB (publ), corporate identity number 556561-0424 (“the Company”), are hereby invited to attend the Annual General Meeting of shareholders on Tuesday March 31, 2020 at 15.00 at World Trade Center (Floor 7, one floor below the Company’s premises), Mässans gata 10 in Gothenburg, Sweden. Registration Shareholders who wish to attend the Annual General Meeting (AGM) must: - be entered in their own name (not through a nominee) in the register of shareholders maintained by Euroclear Sweden AB (“Euroclear”) on Wednesday March 25, 2020 and - notify

There are no items matching the current filter
There are no more items matching the current filter
Back to top